Cargando…

Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy

BACKGROUND: Given the documented benefits of Patient Own Drugs (PODs) in most developed countries and scanty data on PODs management in developing countries the aim of the study was to evaluate the assessment, quality and extent of PODs use among hospitalised patients. Furthermore the perceived bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Boachie-Ansah, Pauline, Anto, Berko Panyin, Marfo, Afia Frimpomaa Asare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329137/
https://www.ncbi.nlm.nih.gov/pubmed/30634970
http://dx.doi.org/10.1186/s12913-018-3860-9
_version_ 1783386777979977728
author Boachie-Ansah, Pauline
Anto, Berko Panyin
Marfo, Afia Frimpomaa Asare
author_facet Boachie-Ansah, Pauline
Anto, Berko Panyin
Marfo, Afia Frimpomaa Asare
author_sort Boachie-Ansah, Pauline
collection PubMed
description BACKGROUND: Given the documented benefits of Patient Own Drugs (PODs) in most developed countries and scanty data on PODs management in developing countries the aim of the study was to evaluate the assessment, quality and extent of PODs use among hospitalised patients. Furthermore the perceived benefits and challenges in executing PODs management by the pharmacy staff in the hospital setting were explored. METHOD: This was a cross-sectional descriptive study. Three hundred patients with chronic diseases admitted in a teaching hospital were purposively sampled. Quality assessment criteria was developed as part of the data collection tool for assessing the quality of PODs. Furthermore, two ward pharmacists and two in-charge nurses at the medical ward were purposively sampled for a face to face interview using an interview guide to find out the hospitals’ medicines management system and policy for PODs. In addition, 130 pharmacy staff were interviewed using a structured questionnaire to find out how PODs were managed. Data was analysed with SPSS version 17. RESULTS: The study showed that 140 (46.6%) of patients brought their PODs on admission. Of these, only 38 (12.7%) were told to bring them whenever they were on admission. Of the 115 (38.3) patients whose PODs were documented as part of medication history, 28 (24.3%) of them had their PODs continued whilst on admission and 11(9.5%) of discharged prescription included PODs. In assessing the quality of PODs 61.6% of 845 PODs were suitable for reuse. Only 19.8% of pharmacy staff attested to the fact that all PODs identified were assessed. The common benefit of PODs cited by pharmacy staff was improving medication history taking whilst the major challenge was difficulty in determining the expiry dates of PODs without original packages. CONCLUSION: About a half of patients with chronic diseases brought PODs with them on admission. The majority of PODs appeared to be suitable for use as presented but only a few were actually used for the patients. Most pharmacy staff were not involved in patients own drugs management at the hospital. There is the need for a policy to streamline PODs management in the teaching hospital. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3860-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6329137
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63291372019-01-16 Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy Boachie-Ansah, Pauline Anto, Berko Panyin Marfo, Afia Frimpomaa Asare BMC Health Serv Res Research Article BACKGROUND: Given the documented benefits of Patient Own Drugs (PODs) in most developed countries and scanty data on PODs management in developing countries the aim of the study was to evaluate the assessment, quality and extent of PODs use among hospitalised patients. Furthermore the perceived benefits and challenges in executing PODs management by the pharmacy staff in the hospital setting were explored. METHOD: This was a cross-sectional descriptive study. Three hundred patients with chronic diseases admitted in a teaching hospital were purposively sampled. Quality assessment criteria was developed as part of the data collection tool for assessing the quality of PODs. Furthermore, two ward pharmacists and two in-charge nurses at the medical ward were purposively sampled for a face to face interview using an interview guide to find out the hospitals’ medicines management system and policy for PODs. In addition, 130 pharmacy staff were interviewed using a structured questionnaire to find out how PODs were managed. Data was analysed with SPSS version 17. RESULTS: The study showed that 140 (46.6%) of patients brought their PODs on admission. Of these, only 38 (12.7%) were told to bring them whenever they were on admission. Of the 115 (38.3) patients whose PODs were documented as part of medication history, 28 (24.3%) of them had their PODs continued whilst on admission and 11(9.5%) of discharged prescription included PODs. In assessing the quality of PODs 61.6% of 845 PODs were suitable for reuse. Only 19.8% of pharmacy staff attested to the fact that all PODs identified were assessed. The common benefit of PODs cited by pharmacy staff was improving medication history taking whilst the major challenge was difficulty in determining the expiry dates of PODs without original packages. CONCLUSION: About a half of patients with chronic diseases brought PODs with them on admission. The majority of PODs appeared to be suitable for use as presented but only a few were actually used for the patients. Most pharmacy staff were not involved in patients own drugs management at the hospital. There is the need for a policy to streamline PODs management in the teaching hospital. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3860-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-11 /pmc/articles/PMC6329137/ /pubmed/30634970 http://dx.doi.org/10.1186/s12913-018-3860-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Boachie-Ansah, Pauline
Anto, Berko Panyin
Marfo, Afia Frimpomaa Asare
Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title_full Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title_fullStr Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title_full_unstemmed Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title_short Reuse of patients’ own drugs in hospitals in Ghana; the evidence to support policy
title_sort reuse of patients’ own drugs in hospitals in ghana; the evidence to support policy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329137/
https://www.ncbi.nlm.nih.gov/pubmed/30634970
http://dx.doi.org/10.1186/s12913-018-3860-9
work_keys_str_mv AT boachieansahpauline reuseofpatientsowndrugsinhospitalsinghanatheevidencetosupportpolicy
AT antoberkopanyin reuseofpatientsowndrugsinhospitalsinghanatheevidencetosupportpolicy
AT marfoafiafrimpomaaasare reuseofpatientsowndrugsinhospitalsinghanatheevidencetosupportpolicy